Safety Assessment of Keratin and Keratin-Derived Ingredients as Used in Cosmetics.

Animals Consumer Product Safety Cosmetics / chemistry Humans Keratins / chemistry Risk Assessment
cosmetics keratin safety

Journal

International journal of toxicology
ISSN: 1092-874X
Titre abrégé: Int J Toxicol
Pays: United States
ID NLM: 9708436

Informations de publication

Date de publication:
10 2021
Historique:
entrez: 13 9 2021
pubmed: 14 9 2021
medline: 27 1 2022
Statut: ppublish

Résumé

The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 8 keratin-derived ingredients, which function mainly as skin and hair conditioning agents in personal care products. The Panel reviewed relevant data provided in this safety assessment and concluded that the 8 keratin-derived ingredients are safe in the present practices of use and concentration described in this safety assessment.

Identifiants

DOI: 10.1177/10915818211013019 PMID: 34514894
pubmed: 34514894
doi: 10.1177/10915818211013019
doi:

Substances chimiques

Cosmetics 0
Keratins 68238-35-7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

36S-51S

Auteurs

Christina L Burnett (CL)

44002Cosmetic Ingredient Review Senior Scientific Analyst/Writer.

Wilma F Bergfeld (WF)

Expert Panel for Cosmetic Ingredient Safety Member.

Donald V Belsito (DV)

Expert Panel for Cosmetic Ingredient Safety Member.

Ronald A Hill (RA)

Expert Panel for Cosmetic Ingredient Safety Former Member.

Curtis D Klaassen (CD)

Expert Panel for Cosmetic Ingredient Safety Member.

Daniel C Liebler (DC)

Expert Panel for Cosmetic Ingredient Safety Member.

James G Marks (JG)

Expert Panel for Cosmetic Ingredient Safety Former Member.

Ronald C Shank (RC)

Expert Panel for Cosmetic Ingredient Safety Member.

Thomas J Slaga (TJ)

Expert Panel for Cosmetic Ingredient Safety Member.

Paul W Snyder (PW)

Expert Panel for Cosmetic Ingredient Safety Member.

Lillian J Gill (LJ)

44002Cosmetic Ingredient Review Former Director.

Bart Heldreth (B)

44002Cosmetic Ingredient Review Executive Director.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Safety Assessment of Keratin and...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Sécurité des produits de consommation › Safety Assessment of Keratin and...
questionsmedicales.fr › Technologie, industrie et agriculture › Produits domestiques › Cosmétiques › Safety Assessment of Keratin and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Safety Assessment of Keratin and...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Scléroprotéines › Kératines › Safety Assessment of Keratin and...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Appréciation des risques › Safety Assessment of Keratin and...